Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history.
- DOI
- 10.1186/s12931-024-02918-8
- Published
- 2024 Aug 5
- Container
- Respiratory research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12931-024-02918-8,
title = {Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history.},
author = {Muro S and Kawayama T and Sugiura H and Seki M and Duncan EA and Bowen K and Marshall J and Megally A and Patel M},
year = {2024},
journal = {Respiratory research},
doi = {10.1186/s12931-024-02918-8},
url = {https://doi.org/10.1186/s12931-024-02918-8}
}RIS
TY - JOUR TI - Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history. AU - Muro S AU - Kawayama T AU - Sugiura H AU - Seki M AU - Duncan EA AU - Bowen K AU - Marshall J AU - Megally A AU - Patel M PY - 2024 JO - Respiratory research DO - 10.1186/s12931-024-02918-8 UR - https://doi.org/10.1186/s12931-024-02918-8 ER -
APA
S, M., T, K., H, S., M, S., EA, D., K, B., J, M., A, M., & M, P. (2024). Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history.. Respiratory research. https://doi.org/10.1186/s12931-024-02918-8
Source records
- pubmed · retrieved 2026-09-26T14:30:25.545Z